CRYSTAL BIOSCIENCE
Crystal Bioscience is a privately-held company that was founded in 2008 to develop a therapeutic antibody discovery engine using chickens. Its platform relies on the large phylogenetic distance between mammals and birds to generate a diverse array of antibodies to human targets that have proven intractable in mammalian and other discovery platforms.
CRYSTAL BIOSCIENCE
Industry:
Biotechnology Pharmaceutical
Founded:
2008-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.crystalbioscience.com
Status:
Active
Contact:
(510)250-7800
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Font API Microsoft Exchange Online Amazon Office 365 Mail Google Maps GStatic Google Static Content Google Maps API Amazon Virginia Region Network Solutions DNS
Similar Organizations
Ab Initio Biotherapeutics
Ab Initio Biotherapeutics operates as an antigen-discovery company.
Hansen Engine
Hansen Engine is a independent research company.
InDanio Bioscience
InDanio Bioscience Inc is a privately-held in vivo drug discovery company.
Sanford Biosciences
Sanford Biosciences is a biotech company.
Y-Biologics
Y-Biologics is specialized in antibody drug since its inception has focused on research and development
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-12-10 | OncoPep | Crystal Bioscience investment in Series D - OncoPep | 11 M USD |
Official Site Inspections
http://www.crystalbioscience.com
Unable to get host informations!!!
More informations about "Crystal Bioscience" on Search Engine
Crystal Bioscience - Crunchbase Company Profile
Founders Robert Etches. Operating Status Closed. Company Type For Profit. Contact Email [email protected]. Phone Number (510)250-7800. Crystal Bioscience is a privately-held company that was founded in 2008 to develop a therapeutic antibody โฆSee details»
Ligand to Acquire Crystal Bioscience, the Leader in Chicken
Oct 4, 2017 SAN DIEGO & EMERYVILLE, Calif.โ(BUSINESS WIRE)โ Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Crystal Bioscience, Inc. โฆSee details»
Ligand (LGND) Signs Deal to Acquire Crystal Bioscience - Yahoo โฆ
Oct 5, 2017 Ligand Pharmaceuticals Incorporated LGND inked a deal to acquire Crystal Bioscience, Inc. for $25 million in cash. The company will also pay an additional $10.5 million to the shareholders of...See details»
Crystal Bioscience - Funding, Financials, Valuation
Dec 10, 2021 Crystal Bioscience has made 2 investments. Their most recent investment was on Dec 10, 2021, when OncoPep raised. $11M. . How many investments has this โฆSee details»
Crystal Bio Welcomes Dr. Shiaw-Lin (Billy) Wu as Co-Founder
Jan 29, 2024 We are thrilled to announce that Dr. Shiaw-Lin (Billy) Wu has joined Crystal Bio as its new co-founder and Chief Scientific Officer (CSO). With over three decades of โฆSee details»
Team - OmniAb
Prior to Crystal, Dr. Harriman was an R&D Director at Trellis Bioscience, where he managed antibody discovery projects and was co-inventor of the companyโs CellSpot โฆSee details»
Crystal Bioscience - Products, Competitors, Financials, โฆ
Crystal Bioscience. Unclaimed. crystalbioscience.com. Overview & Products. Financials. People. Stage. Acquired | Acquired. Valuation. $0000. View. About Crystal Bioscience. โฆSee details»
Ligand (LGND) Signs Deal to Acquire Crystal Bioscience
Oct 5, 2017 Ligand Pharmaceuticals Incorporated LGND inked a deal to acquire Crystal Bioscience, Inc. for $25 million in cash. The company will also pay an additional $10.5 million to the shareholders of...See details»
Crystal Bioscience and Open Monoclonal Technology Announce โฆ
Published: Dec 04, 2012. PALO ALTO, Calif. & EMERYVILLE, Calif.-- (BUSINESS WIRE)--Open Monoclonal Technology, Inc. (OMT) and Crystal Bioscience, Inc. (Crystal) today โฆSee details»
Crystal Bioscience and Boehringer Ingelheim announce multiple โฆ
Jan 7, 2014 Crystal Bioscience will apply its proprietary gel encapsulated microenvironment (GEM) and chicken immunization platforms to discover antibodies to โฆSee details»
Crystal Bioscience acquired by Ligand Pharmaceuticals
Ligand Pharmaceuticals acquires Crystal Bioscience on 2017-10-04 for $35500000. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. โฆSee details»
Crystal Bioscience Develops First Non-Mammalian, Fully-Human ... - BioSpace
Feb 26, 2016 Back to news. Crystal Bioscience Develops First Non-Mammalian, Fully-Human Monoclonal Antibody Platform - Reaching A New Universe Of Novel Epitopes - read this article along with other careers information, tips and advice on BioSpace.See details»
CRYSTAL BIOSCIENCE, INC. | VentureRadar
Dec 31, 2016 CRYSTAL BIOSCIENCE, INC. VentureRadar profile. Find out more about CRYSTAL BIOSCIENCE, INC. including the VentureRadar Innovation and Growth โฆSee details»
BRIEF-Ligand to acquire Crystal Bioscience | Reuters
Oct 4, 2017 * Ligand to acquire Crystal Bioscience, the leader in chicken-derived fully-human antibody generation, for $25 million in cash plus additional potential paymentsSee details»
Crystal Biosciences - Funding & Investors - Tracxn
Apr 23, 2024 Specialty company developing antibodies. Last updated: April 23, 2024. Summary of Funding Rounds of Crystal Biosciences. Funding Rounds. 1 Grant (prize โฆSee details»
Crystal Bioscience - PitchBook
Contact Information. site. www.crystalbioscience.com. Ownership Status. Acquired/Merged. Financing Status. Corporate Backed or Acquired. Primary Industry. Discovery Tools (Healthcare) Other Industries. Biotechnology. Drug Discovery. Acquirer. Ligand Pharmaceuticals. Corporate Office. 5980 Horton Street. Suite 405. Emeryville, CA โฆSee details»
Crystal Bioscience Announces Expansion of Its Collaboration with ...
Dec 21, 2016 Crystal Bioscience is a privately held company that was founded in 2008 to develop a world-class therapeutic antibody discovery engine using chickens.See details»
OBIO Announces New Chair of the Board of Directors, Dr. Maura โฆ
Mar 4, 2021 The Ontario Bioscience Innovation Organization (OBIO ®) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, โฆSee details»
Crystal Bioscience, BI Set to Collaborate on Antibody Discovery
January 7, 2014. California-based Crystal Bioscience and Germanyโs Boehringer Ingelheim have inked a deal to collaborate on discovering and developing therapeutic antibodies, the drugmakers said Tuesday.See details»
2022 OBIO Investment Summit - Ontario Bioscience Innovation โฆ
2022 OBIO Investment Summit. Wednesday, February 9, 2022 9:00 AM. Friday, February 11, 2022 5:00 PM. Ontario Bioscience Innovation Organization 100 College St., Suite โฆSee details»